Results 321 to 330 of about 149,286 (348)

Development of a trispecific fusion protein based on angiotensin-converting enzyme 2, glycoprotein 130, and tumor necrosis factor receptor 2 as a promising therapeutic for COVID-19. [PDF]

open access: yesMol Biomed
Qiao Y   +19 more
europepmc   +1 more source

Artificial Intelligence Reveals Nature: Functional Parallels Between a Designed and a Natural Peptide. [PDF]

open access: yesInt J Mol Sci
Wang J   +10 more
europepmc   +1 more source

SARS-CoV-2 Entry Can Be Mimicked in <i>C. elegans</i> Expressing Human ACE2: A New Tool for Pharmacological Studies. [PDF]

open access: yesViruses
Romeo M   +8 more
europepmc   +1 more source

Autoimmune reactions to ACE2 triggered by SARS-CoV-2 S protein and their histopathological consequences. [PDF]

open access: yesSci Rep
Beduleva L   +9 more
europepmc   +1 more source

Targeting SIRT1: A Potential Strategy for Combating Severe COVID-19. [PDF]

open access: yesBiomed Res Int
Shokri-Afra H   +7 more
europepmc   +1 more source

Insights into the role of dynamical features in protein complex formation: The case of SARS-CoV-2 spike binding with ACE2. [PDF]

open access: yesComput Struct Biotechnol J
Grassmann G   +6 more
europepmc   +1 more source

Angiotensin-Converting Enzyme Inhibitors to Prevent Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: Scientific Speculation or an Opportunity to Improve Real Clinical Practice? [PDF]

open access: yesInt J Mol Sci
Seidita A   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy